| # | Holder | Shares | % of Shares Out | Change | Filing Date |
|---|---|---|---|---|---|
| 1 |
China Resources Co Ltd
|
3.355b | 53.40% | +21.601m | Dec 31 2024 |
| 2 |
Beijing State-owned Capital Operation and Management Company Limited
|
1.095b | 17.43% | — | Dec 31 2024 |
| 3 |
Beijing Equity Investment Development Fund (Cayman II) L.P.
|
34.682m | 0.55% | -63.423m | Oct 18 2024 |
| 4 |
Dimensional Fund Advisors, L.P.
|
34.483m | 0.55% | +42.000k | Apr 30 2026 |
| 5 |
The Vanguard Group, Inc.
|
31.610m | 0.50% | -29.378m | Apr 30 2026 |
|
1
China Resources Co Ltd
|
53.40%
3.355b
|
|
2
Beijing State-owned Capital Operation and Management Company Limited
|
17.43%
1.095b
|
|
3
Beijing Equity Investment Development Fund (Cayman II) L.P.
|
0.55%
34.682m
|
|
4
Dimensional Fund Advisors, L.P.
|
0.55%
34.483m
|
|
5
The Vanguard Group, Inc.
|
0.50%
31.610m
|
| The largest shareholders show who really holds influence: big institutional owners shape a stock's liquidity, and building or cutting positions can move the price. | |
| The 5 largest shareholders together hold 72.43% of China Resources Pharmaceutic, with China Resources Co Ltd the biggest at 53.40%, followed by Beijing State-owned Capital Operation and Management Company Limited (17.43%) and Beijing Equity Investment Development Fund (Cayman II) L.P. (0.55%). |
StocksGuide is the ultimate tool for easily finding, analyzing and tracking stocks. Learn from successful investors and make informed investment decisions. We empower you to become a confident, independent investor.


